Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 526 - 550 of 561 in total

ISOTHIAZOLIDINONE ANALOG

Experimental

Ersodetug

Investigational

Iluzanebart

Investigational

LJP 1082

LJP 1082 is a Toleragen that is designed to shut down the B cells that produce antibodies to ß2 GP1. LJP 1082 is undergoing trial for for the treatment of stroke, deep-vein thrombosis and other conditions associated with antibody-mediated thrombosis. Antibody-mediated thrombosis, also called antiphospholipid syndrome (APS), is a blood...
Investigational

(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene

Experimental

S-octylglutathione

Experimental

S-Hexylglutathione

Experimental

4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol

Experimental

Canfosfamide

Canfosfamide is an active agent in chemotherapy-resistant ovarian cancer.
Investigational

CTT-1057

CTT-1057 is under investigation in clinical trial NCT03427476 (CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma).
Investigational

Golotimod

SCV-07 (g -D-glutamyl-L-tryptophan) is a novel synthetic dipeptide that acts broadly on the Toll-like receptor pathway. It has been shown to stimulate T-lymphocyte differentiation, macrocytic phagocytosis, and specific immune responses, and enhance IL-2 and INF-g production. Due to this preferential activation of Th1 cytokine production, SCV-07 may show utility in...
Investigational

N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine

Experimental

Glutathione sulfonic acid

Experimental

S-benzylglutathione

Experimental

S-Hydroxymethyl Glutathione

Experimental

(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene

Experimental

GLUTATHIONE SULFINATE

Experimental

Z-Val-Ala-Asp fluoromethyl ketone

Non-methylated, competitive, and irreversible inhibitor of caspase 1, as well as other caspases,1 which can be used directly with purified enzymes. It does not require an esterase to hydrolyze the O-methyl ester like the cell-permeable form, Z-Val-Ala-Asp(O-Me) fluoromethyl ketone.
Experimental

Emricasan

Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA. It is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.
Investigational

S-(4-nitrobenzyl)glutathione

Experimental

Ulviprubart

Investigational

S-P-Nitrobenzyloxycarbonylglutathione

Experimental

Triglu-5-formyl-tetrahydrofolate

Experimental

Glutathione S-atrazine

Experimental

S-(2,4-dinitrophenyl)glutathione

Experimental
Displaying drugs 526 - 550 of 561 in total